Cargando…

Is the Expression of Androgen Receptor Protein Associated With the Length of AC Repeats in the Type III 5-α Reductase Gene in Prostate Cancer Patients?

PURPOSE: Type III 5-α reductase (SRD5A3; steroid 5-α reductase 3) may be associated with the progression of prostate cancer (PCa). The aim of our study was to determine whether the length of AC repeats in the SRD5A3 gene is associated with the risk of PCa and the expression of androgen receptor (AR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jong Mok, Song, Ki Hak, Lim, Jae Sung, Kim, Jin Woo, Sul, Chong Koo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685642/ https://www.ncbi.nlm.nih.gov/pubmed/23789051 http://dx.doi.org/10.4111/kju.2013.54.6.404

Ejemplares similares

Combined effect of polymorphisms in type III 5-α reductase and androgen receptor gene with the risk of benign prostatic hyperplasia in Korea
por: Lee, Chung Lyul, et al.
Publicado: (2016)

Neoadjuvant Hormonal Therapy Preceding Radical Prostatectomy for Clinically Localized Prostate Cancer: Early Postoperative Complications and Biochemical Recurrence
por: Yang, Seung Woo, et al.
Publicado: (2011)

Androgen Regulation of 5α-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention
por: Li, Jin, et al.
Publicado: (2011)

The impact of finasteride and dutasteride treatments on proliferation, apoptosis, androgen receptor, 5α-reductase 1 and 5α-reductase 2 in TRAMP mouse prostates
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2017)

Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy
por: Heo, Ji Eun, et al.
Publicado: (2018)

Differences of adrenal‐derived androgens in 5α‐reductase deficiency versus androgen insensitivity syndrome
por: Han, Bing, et al.
Publicado: (2021)

Corni Fructus attenuates testosterone-induced benign prostatic hyperplasia by suppressing 5α-reductase and androgen receptor expression in rats
por: Hwangbo, Hyun, et al.
Publicado: (2018)

Length and somatic mosaicism of CAG and GGN repeats in the androgen receptor gene and the risk of prostate cancer in men with benign prostatic hyperplasia
por: Tayeb, Mohammed T., et al.
Publicado: (2004)

Comparison of Laparoscopic Radiofrequency Ablation and Open Partial Nephrectomy in Patients With a Small Renal Mass
por: Youn, Chang Shik, et al.
Publicado: (2013)

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
por: Bratt, O, et al.
Publicado: (1999)

Handedness and the X chromosome: The role of androgen receptor CAG-repeat length
por: Arning, Larissa, et al.
Publicado: (2015)

Bioengineered polyester nanoparticles for the synergistic treatment of androgenic alopecia via the suppression of 5α-reductase and knockdown of androgen receptor
por: Chen, Xiangru, et al.
Publicado: (2022)

Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
por: Xiao, Qingpin, et al.
Publicado: (2020)

Structure of human steroid 5α-reductase 2 with anti-androgen drug finasteride
por: Xiao, Qingpin, et al.
Publicado: (2020)

Effects of Androgen Treatment on Growth in Patients with 5-α-Reductase Type 2 Deficiency
por: Lee, Hae In, et al.
Publicado: (2023)

CAG Repeat Number in the Androgen Receptor Gene and Prostate Cancer
por: Madjunkova, S, et al.
Publicado: (2012)

Positive Correlation between Androgen Receptor CAG Repeat Length and Metabolic Syndrome in a Korean Male Population
por: Kim, Jong Wook, et al.
Publicado: (2018)

Effect of Shifting from Combination Therapy to Monotherapy of α-Blockers or 5α-Reductase Inhibitors on Prostate Volume and Symptoms in Patients with Benign Prostatic Hyperplasia
por: Kim, Hyoung Woo, et al.
Publicado: (2011)

Association between polymorphic CAG repeat lengths in the androgen receptor gene and susceptibility to prostate cancer: A systematic review and meta-analysis
por: Qin, Zhiqiang, et al.
Publicado: (2017)

AB172. Androgen receptor CAG repeat length polymorphism is associated with risk of metabolic syndrome in a Korean male
por: Yoon, Cheol Yong, et al.
Publicado: (2014)

Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model
por: Lee, Gyuok, et al.
Publicado: (2017)

Androgen Receptor CAG Repeats Length Polymorphism and the Risk of Polycystic Ovarian Syndrome (PCOS)
por: Rajender, Singh, et al.
Publicado: (2013)

Association of androgen receptor GGN repeat length polymorphism and male infertility in Khuzestan, Iran
por: Moghadam, Mohamad, et al.
Publicado: (2015)

Androgen receptor CAG and GGN repeat length variation contributes more to the tumorigenesis of osteosarcoma
por: Shi, Yongxiang, et al.
Publicado: (2016)

Androgen Receptor CAG Repeat Length as a Risk Factor of Late-Onset Hypogonadism in a Korean Male Population
por: Kim, Jong Wook, et al.
Publicado: (2018)

Expression of Aquaporin-3 in Ipsilateral Rat Kidney With Unilateral Partial Ureteral Obstruction
por: Lee, Ji Yong, et al.
Publicado: (2013)

Mixture of Corni Fructus and Schisandrae Fructus improves testosterone-induced benign prostatic hyperplasia through regulating 5α-reductase 2 and androgen receptor
por: Hwangbo, Hyun, et al.
Publicado: (2023)

Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors
por: Koo, Kyo Chul, et al.
Publicado: (2013)

Expression of 5α‐Reductases in Human Epithelial Ovarian Cancer: Its Correlation with Androgen Receptor Status
por: Akahira, Jun‐Ichi, et al.
Publicado: (2001)

Correction: Androgen Receptor CAG Repeats Length Polymorphism and the Risk of Polycystic Ovarian Syndrome (PCOS)
por: Rajender, Singh, et al.
Publicado: (2013)

Correction: Androgen Receptor CAG Repeats Length Polymorphism and the Risk of Polycystic Ovarian Syndrome (PCOS)
por: Rajender, Singh, et al.
Publicado: (2013)

The androgen receptor cytosine-adenine-guanine repeat length contributes to the development of epithelial ovarian cancer
por: Meng, Xiangrui, et al.
Publicado: (2015)

Retraction: Androgen receptor CAG and GGN repeat length variation contributes more to the tumorigenesis of osteosarcoma
por: Shi, Yongxiang, et al.
Publicado: (2017)

Pinostilbene inhibits full-length and splice variant of androgen receptor in prostate cancer
por: Shin, Won Sik, et al.
Publicado: (2023)

Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer
por: Cottard, Félicie, et al.
Publicado: (2017)

Current Status of 5α-Reductase Inhibitors in Prostate Disease Management
por: Kang, Dong Il, et al.
Publicado: (2013)

Is DHT Production by 5α-Reductase Friend or Foe in Prostate Cancer?
por: Kosaka, Takeo, et al.
Publicado: (2014)

AB080. Correlation between androgen receptor CAG repeat length polymorphism and metabolic syndrome, late onset hypogonadism in Korean male
por: Park, Jong Jin, et al.
Publicado: (2016)

Simultaneous pharmacokinetic and pharmacodynamic analysis of 5α-reductase inhibitors and androgens by liquid chromatography tandem mass spectrometry
por: Upreti, Rita, et al.
Publicado: (2015)

Size Matters: The CAG Repeat Length of the Androgen Receptor Gene, Testosterone, and Male Adolescent Depression Severity
por: Hirtz, Raphael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m7aoqogug4a6ea6kli6uo5dhu1